1.
NSCLC肺癌患者与对照组之间凝血功能指标的比较
The values of serum coagulation tests in patients with NSCLC and controls
Coagulation tests | Patients (n=604) | Controls (n=50) | P | |||
Median | Range | Median | Range | |||
NSCLC: non-small cell lung cancer; PT: prothrombin time; PTA: prothrombin time activity; INR: international normalized ratio; APTT: activated partial thromboplastin time; Fib: fibrinogen; PLT: platelet count. | ||||||
PT (s) | 11.3 | 9.5-26.6 | 10.1 | 8.8-10.6 | <0.001 | |
PTA (%) | 99 | 33-142 | 114 | 106-139 | 0.001, 5 | |
INR | 1.04 | 0.88-2.10 | 0.93 | 0.84-0.97 | <0.001 | |
APTT (s) | 32.0 | 20.9-55.4 | 32.4 | 29.8-33.4 | <0.001 | |
Fib (g/L) | 4.21 | 2.13-10.10 | 2.26 | 1.97-3.82 | <0.001 | |
D-dimer (mg/L) | 0.2 | 0.1-8.2 | 0.1 | 0.1-0.2 | <0.001 | |
PLT (×109/L) | 271 | 130-675 | 217 | 119-247 | 0.004, 5 |